Team Member

Adam Rusin is a seasoned executive with over 25 years of experience in the pharmaceutical and medical technology sectors. As a Member of the Management Board at BrainScan S.A., he is responsible for strategic partnerships and driving the company’s international expansion. Under his leadership, BrainScan signed a pivotal agreement with Israeli company Aidoc, opening doors to new markets across Europe, North America, and Asia.

Before joining BrainScan, Adam gained extensive experience in renowned pharmaceutical companies such as Polpharma and Pliva S.A., where he oversaw product portfolio development and expansion into Central and Eastern European markets. He also held executive roles at Herbapol Lublin S.A., where, as Director of Marketing and Business Development, he implemented innovative growth strategies and successfully managed cross-functional teams.

Adam holds a Master of Science degree in Biotechnology from Wrocław University of Science and Technology. He further enhanced his expertise with postgraduate studies in Industrial Pharmacy at the Medical University of Gdańsk and an MBA jointly conducted by the Warsaw School of Economics and the Université du Québec à Montréal (UQAM). His multidisciplinary background enables him to bridge business innovation with healthcare needs, making him a key driver of BrainScan’s mission to revolutionize medical diagnostics with AI.